Walking Dead Alum Reveals Stage 4 Cancer Diagnosis; Cast and crew gather around ‘One of Our Own’
The Walking dead The family arrives in the midst of a serious medical crisis for one of their colleagues.
Franchise CCO announced on Monday that Erik Jensen – who starred in Season 5 Steven EdwardsThe weaselly Grady Memorial doctor, for whom the hapless Beth Greene briefly worked as an assistant, was diagnosed with stage IV colon cancer.
More from TVLine
Gimple shared the sobering news on social media and alerted fans to it GoFundMe Page created on behalf of the actor.
“One of TWD“Yourself could use a little help,” Gimple continued X (formerly known as Twitter). “Erik Jensen, the Dr. Steven Edwards, who played in S5, has just been diagnosed with cancer and it is a time of great uncertainty for him and his family.”
The GoFundMe page states that Jensen and his family – which includes his wife Jessica and their 13-year-old daughter Sadie – are “facing the fight of their lives,” adding: “Erik and Jess… are full-time freelance artists and live.” without the buffer that long-term commercial work can provide.” The two strikes in Hollywood only made their “extremely precarious financial situation” even worse and left them needing “a lot of help to get through the next year “To pay for treatment, keep her home and ensure some stability for Sadie.”
The message ends with this hopeful note: “Stage IV is not a death sentence, and Erik is working incredibly hard to stay positive and fight for the vaccination that his doctors say he has.”
Walking dead Veterinarian Jeffrey Dean Morgan – who comes from the first season of AMC TWD: Dead City Spinoff – reiterated Gimple’s call to action on Tuesday on X, writing: “I never had the opportunity to work with Erik. [But] I’ve heard a lot about what a great guy he is. I know him and his [family] Could use some help.”
In addition to his recurring role in The walking deadJensen’s TV appearances include: Mr Robot, Mindhunter, The Americans And 30 Rock.
The best of TVLine
Get more from TVLine.com: Follow us on Twitter, Facebook, Newsletter
